Neuroendocrinology

Original Paper

Ultrastructural Evidence of a Sexual Dimorphism in the Neuropil of the Medial Preoptic Nucleus of the Rat: A Quantitative Study

Larriva-Sahd J.

Author affiliations

Experimental Pathology Laboratory, Department of Pathology, National Institute of Nutrition, Mexico City, Mexico

Related Articles for ""

Neuroendocrinology 1991;54:416–419

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: October 05, 1990
Accepted: March 01, 1991
Published online: April 07, 2008
Issue release date: 1991

Number of Print Pages: 4
Number of Figures: 0
Number of Tables: 0

ISSN: 0028-3835 (Print)
eISSN: 1423-0194 (Online)

For additional information: https://www.karger.com/NEN

Abstract

In the rat, a new structural sex difference of the nervous system was found: the density of axodendritic synapses (ADS) is larger in the male central component of the medial preoptic nucleus (MPNc), as proven by quantitative electron microscopy. The study included 24 animals divided into four groups (n = 6): control males (CM), control females (CF), males castrated as newborn (MGx) and males castrated as newborn and treated 10 days with daily injections of testosterone. No significant differences were found in the number of axospinous synapses among all groups; however, the number of ADS was significantly larger in CM when compared to that of the CF. This difference was abrogated by castration of the newborn male and restored by perinatal treatment with testosterone. Further, no difference in ADS was encountered between CF and MGx. The present data, together with previous studies which indicate that sex steroids do modify the number of synapses in other nuclei of the brain, led us to conclude that the sex difference in the number of ADS within the MPNc is determined by the organizational effect(s) of testosterone.

© 1991 S. Karger AG, Basel




Related Articles:


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: October 05, 1990
Accepted: March 01, 1991
Published online: April 07, 2008
Issue release date: 1991

Number of Print Pages: 4
Number of Figures: 0
Number of Tables: 0

ISSN: 0028-3835 (Print)
eISSN: 1423-0194 (Online)

For additional information: https://www.karger.com/NEN


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP